ResearchMoz

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014

GlobalData
Published Date » 2014-06-20
No. Of Pages » 159
   
 Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2014 provides data on the Bipolar Disorder (Manic Depression) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bipolar Disorder (Manic Depression). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bipolar Disorder (Manic Depression). This report is built using data and information sourced from proprietary databases, primary and secondary research and...
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bipolar Disorder (Manic Depression) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bipolar Disorder (Manic Depression) 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Bipolar Disorder (Manic Depression) 38
Mar 31, 2014: Forest Laboratories and Gedeon Richter Announce Positive Phase IIb Topline Results for Cariprazine for the Treatment of Bipolar Depression 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Eli Lilly and Company 44
Clinical Trial Overview of Eli Lilly and Company 44
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Johnson & Johnson 50
Clinical Trial Overview of Johnson & Johnson 50
Otsuka Holdings Co., Ltd. 53
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 53
GlaxoSmithKline plc 56
Clinical Trial Overview of GlaxoSmithKline plc 56
Abbott Laboratories 58
Clinical Trial Overview of Abbott Laboratories 58
Merck & Co., Inc. 60
Clinical Trial Overview of Merck & Co., Inc. 60
Bristol-Myers Squibb Company 62
Clinical Trial Overview of Bristol-Myers Squibb Company 62
Novartis AG 64
Clinical Trial Overview of Novartis AG 64
Clinical Trial Overview of Top Institutes / Government 66
National Institute of Mental Health 66
Clinical Trial Overview of National Institute of Mental Health 66
Massachusetts General Hospital 69
Clinical Trial Overview of Massachusetts General Hospital 69
University of Pittsburgh 72
Clinical Trial Overview of University of Pittsburgh 72
U.S. Department of Veterans Affairs 73
Clinical Trial Overview of U.S. Department of Veterans Affairs 73
Mclean Hospital 74
Clinical Trial Overview of Mclean Hospital 74
University of Texas Southwestern Medical Center at Dallas 75
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 75
University of Cincinnati 76
Clinical Trial Overview of University of Cincinnati 76
University of British Columbia 77
Clinical Trial Overview of University of British Columbia 77
University Hospitals of Cleveland 78
Clinical Trial Overview of University Hospitals of Cleveland 78
Lindner Center of HOPE 79
Clinical Trial Overview of Lindner Center of HOPE 79
Five Key Clinical Profiles 80

Appendix 157
Abbreviations 157
Definitions 157
Research Methodology 158
Secondary Research 158
About GlobalData 159
Contact Us 159
Disclaimer 159
Source 159

List of Tables


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bipolar Disorder (Manic Depression) Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bipolar Disorder (Manic Depression) Therapeutics, Global, Terminated Clinical Trials, 2014* 28
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 39
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 44
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 47
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 50
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 53
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 56
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 58
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 60
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 62
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 64
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 66
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 69
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 72
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 73
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 74
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 75
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 76
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 77
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Cleveland, 2014* 78
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials Market, Global, Clinical Trials by Lindner Center of HOPE, 2014* 79

List of Figures


Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bipolar Disorder (Manic Depression) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bipolar Disorder (Manic Depression) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bipolar Disorder (Manic Depression) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bipolar Disorder (Manic Depression) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bipolar Disorder (Manic Depression) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Bipolar Disorder (Manic Depression) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 158

Upcoming Reports:

Hemostasis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Hemostasis is the phenomenon of interaction between platelets, blood vessels and coagulation protein which helps to stop the bleeding. In addition, this process also maintains the blood flow in the blood vessels. Bleeding disorders could be a result of vascular and coagulation abnormalities. Hemostasis diagnostics helps in detection of these abnormalities and assists in proper treatment. Hemostasis diagnostic tests include Activated Partial Prothrombin Time (APPT), Prothrombin time (PT), and Fibrinogen assay.  PT test is performed by extraction of the blood sample and...
Vaccine Production Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecasts 2012 - 2018
By - Transparency Market Research
High growth rate in emerging markets, technological advancements, strong support from governments and other active associations like WHO and GAVI, and increased investment in research and development are all leading to the overall growth of the vaccine production market. The vaccine production market is expected to exhibit improved performance in the coming years due to the successful launch of new vaccines.  Vaccines for different illnesses are among the top revenue earners in the pharmaceutical industry. Research and development in this field is leading to the...
Carbohydrase Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Carbohydrase is a special type of enzyme that acts as a catalyst for breaking down the carbohydrates into simple sugar. Carbohydrase enzyme is mainly used to convert starch syrup into sugar syrup which is further used as an ingredient in the manufacturing of food and beverages and other applications. Carbohydrase enzymes are indigenously created in the body parts of human beings such as mouth, pancreas and small intestine. These enzymes are used for the digestion of carbohydrates by breaking down starch into sugars. Moreover, the carbohydrase enzymes are commercially produced for use...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...